| The good, the bad, and the opportunities of the complement system in neurodegenerative disease ND Schartz, AJ Tenner Journal of Neuroinflammation 17 (1), 354, 2020 | 232 | 2020 |
| Status epilepticus triggers long-lasting activation of complement C1q-C3 signaling in the hippocampus that correlates with seizure frequency in experimental epilepsy ND Schartz, SK Wyatt-Johnson, LR Price, SA Colin, AL Brewster Neurobiology of Disease 109, 163-173, 2018 | 71 | 2018 |
| Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus ND Schartz, SA Herr, L Madsen, SJ Butts, C Torres, LB Mendez, ... Scientific Reports 6 (1), 24988, 2016 | 62 | 2016 |
| The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis EA Lungwitz, GD Stuber, PL Johnson, AD Dietrich, N Schartz, ... Neuropsychopharmacology 39 (4), 1009-1019, 2014 | 39 | 2014 |
| C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer’s disease A Gomez-Arboledas, K Carvalho, G Balderrama-Gutierrez, SH Chu, ... Acta Neuropathologica Communications 10 (1), 116, 2022 | 35 | 2022 |
| Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression K Carvalho, ND Schartz, G Balderrama-Gutierrez, HY Liang, SH Chu, ... Journal of neuroinflammation 19 (1), 178, 2022 | 32 | 2022 |
| Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus ND Schartz, AL Sommer, SA Colin, LB Mendez, AL Brewster Physiology & behavior 212, 112705, 2019 | 15 | 2019 |
| C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer’s model ND Schartz, HY Liang, K Carvalho, SH Chu, A Mendoza-Arvilla, ... BioRxiv, 2023 | 4 | 2023 |
| Impact of peripheral immune status on central molecular responses to facial nerve axotomy DO Setter, EM Runge, ND Schartz, FM Kennedy, BL Brown, KP McMillan, ... Brain, behavior, and immunity 68, 98-110, 2018 | 4 | 2018 |
| C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer’s disease mouse model ND Schartz, HY Liang, K Carvalho, SH Chu, A Mendoza-Arvilla, ... Nature communications 15 (1), 7028, 2024 | 3 | 2024 |
| C5aR1 signaling promotes region‐and age‐dependent synaptic pruning in models of Alzheimer's disease A Gomez‐Arboledas, MI Fonseca, E Kramar, SH Chu, ND Schartz, ... Alzheimer's & Dementia 20 (3), 2173-2190, 2024 | 3 | 2024 |
| Identification of a resilient mouse facial motoneuron population following target disconnection by injury or disease DO Setter, MM Haulcomb, T Beahrs, RM Meadows, ND Schartz, ... Restorative neurology and neuroscience 36 (3), 417-422, 2018 | 3 | 2018 |
| Mice deficient in complement C3 are protected against recognition memory deficits and astrogliosis induced by status epilepticus ND Schartz, A Aroor, Y Li, N Pinzón-Hoyos, AL Brewster Frontiers in Molecular Neuroscience 16, 1265944, 2023 | 2 | 2023 |
| Gene expression profile analysis of immunodeficient mice after WT or mSOD1 immunoreconsitution reveals differential motoneuron death mechanisms after facial nerve axotomy DO Setter, EM Runge, ND Schartz, VM Sanders, KJ Jones The FASEB Journal 31, 747.1-747.1, 2017 | 1 | 2017 |
| Acute depletion of complement C3 with cobra venom factor attenuates memory deficits induced by status epilepticus ND Schartz, Y Li, AL Sommer, AL Brewster Epilepsia Open 9 (6), 2173-2185, 2024 | | 2024 |
| 67 Strategic targeting of complement to regulate neuroinflammation and synapse pruning in Alzheimer’s disease A Tenner, N Schartz, H Liang, SH Chu, A Gomez-Arboledas, A Mortazavi Immunobiology 228 (5), 152520, 2023 | | 2023 |
| Treatment with C5aR1 antagonist attenuates short‐term hippocampal memory decline and prevents DAM signature in Arctic mice. ND Schartz, K Carvalho, HY Liang, SH Chu, A Mortazavi, AJ Tenner Alzheimer's & Dementia 18, e066806, 2022 | | 2022 |
| C5aR1 deletion delays amyloid-associated inflammatory gene expression and microglial activation in the Arctic model of Alzheimer's disease N Schartz, K Carvalho, A Gomez-Arboledas, G Balderrama-Gutierrez, ... MOLECULAR IMMUNOLOGY 141, 142-142, 2022 | | 2022 |
| C5a overexpression alters gene expression and microglial activation in brain of the Arctic model of Alzheimer's disease N Schartz, K Carvalho, T Petrisko, G Balderrama-Gutierrez, H Liang, ... MOLECULAR IMMUNOLOGY 141, 140-141, 2022 | | 2022 |
| Plasma and serum neurofilament‐light levels increase in an age‐and pathology‐dependent manner in the Arctic mouse model of Alzheimer’s disease ND Schartz, P Selvan, SH Chu, AJ Tenner Alzheimer's & Dementia 17, e056343, 2021 | | 2021 |
Amy L. BrewsterAssociate Professor, Department of Biological Sciences, Southern Methodist UniversityПотвърден имейл адрес: smu.edu